SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/76FF976391E90EEDCB1545449A6CF43A0C07B0F11B4B499D7FF31FA82E86B339E56C3CF49C26EE6F34BEC31E59F9B2B8>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/76FF976391E90EEDCB1545449A6CF43A0C07B0F11B4B499D7FF31FA82E86B339E56C3CF49C26EE6F34BEC31E59F9B2B8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/76FF976391E90EEDCB1545449A6CF43A0C07B0F11B4B499D7FF31FA82E86B339E56C3CF49C26EE6F34BEC31E59F9B2B8
http://www.w3.org/2000/01/rdf-schema#comment
"a new paradigm in which p38gamma actively regulates the drug-Topo IIalpha signal transduction and this may be exploited to increase the therapeutic activity of Topo II drugs."
xsd:string
http://purl.uniprot.org/uniprot/#_C96C8EC63C15B37C698A77FE2C686A1ABFF5D54A2EE31CDF21C479809566994D593F8F62C3C959983C30C2F6F9033377
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/76FF976391E90EEDCB1545449A6CF43A0C07B0F11B4B499D7FF31FA82E86B339E56C3CF49C26EE6F34BEC31E59F9B2B8
http://purl.uniprot.org/uniprot/B5MDL5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/76FF976391E90EEDCB1545449A6CF43A0C07B0F11B4B499D7FF31FA82E86B339E56C3CF49C26EE6F34BEC31E59F9B2B8
http://purl.uniprot.org/uniprot/#_B5MDL5-mappedCitation-21878638
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/76FF976391E90EEDCB1545449A6CF43A0C07B0F11B4B499D7FF31FA82E86B339E56C3CF49C26EE6F34BEC31E59F9B2B8